AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
23:08
Kelemen Hunor states that Nicușor Dan is “absolutely immune to pressure”
22:54
Radu Miruță announces the elimination of the bridge toll at Fetești and Vadu Oii with the implementation of the TollRo system
22:39
A prisoner escaped from a work site in Târgu Jiu but was apprehended approximately one and a half hours later
22:38
A Republican senator calls for a congressional investigation after a Kremlin ally funded festivities for Donald Trump Jr.'s wedding
22:30
Lithuania’s parliament voted to lift the ban on nuclear weapons and foreign military bases
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
